Dr. Kiran Dhillon has a PhD in Genetics from the University of Washington and then studied chemotherapy resistance in BRCA1/2-associated breast and ovarian cancers at the Fred Hutch Cancer Center. She then joined the Rivkin Center as Director of Scientific Programs, where she oversaw an international ovarian cancer research grants program, scientific symposia, and content for a breast and ovarian cancer education program.

Currently, Dr. Dhillon is the Executive Director at the Cancer Vaccine Institute at the University of Washington, the largest academic institution devoted to the development of cancer vaccines. As Executive Director, she directs the overall strategic program goals and general administration of the Institute to accelerate the development of therapeutic and preventative vaccines for some of the most common and deadly cancers, including breast and ovarian cancers.